TY - JOUR
T1 - The prognostic value of pathologic lymph node imaging using deep learning-based outcome prediction in oropharyngeal cancer patients
AU - Ma, Baoqiang
AU - De Biase, Alessia
AU - Guo, Jiapan
AU - van Dijk, Lisanne V
AU - Langendijk, Johannes A
AU - Both, Stefan
AU - van Ooijen, Peter M A
AU - Sijtsema, Nanna M
N1 - Publisher Copyright:
© 2025 The Author(s)
PY - 2025/1
Y1 - 2025/1
N2 - BACKGROUND AND PURPOSE: Deep learning (DL) models can extract prognostic image features from pre-treatment PET/CT scans. The study objective was to explore the potential benefits of incorporating pathologic lymph node (PL) spatial information in addition to that of the primary tumor (PT) in DL-based models for predicting local control (LC), regional control (RC), distant-metastasis-free survival (DMFS), and overall survival (OS) in oropharyngeal cancer (OPC) patients.MATERIALS AND METHODS: The study included 409 OPC patients treated with definitive (chemo)radiotherapy between 2010 and 2022. Patient data, including PET/CT scans, manually contoured PT (GTVp) and PL (GTVln) structures, clinical variables, and endpoints, were collected. Firstly, a DL-based method was employed to segment tumours in PET/CT, resulting in predicted probability maps for PT (TPMp) and PL (TPMln). Secondly, different combinations of CT, PET, manual contours and probability maps from 300 patients were used to train DL-based outcome prediction models for each endpoint through 5-fold cross validation. Model performance, assessed by concordance index (C-index), was evaluated using a test set of 100 patients.RESULTS: Including PL improved the C-index results for all endpoints except LC. For LC, comparable C-indices (around 0.66) were observed between models trained using only PT and those incorporating PL as additional structure. Models trained using PT and PL combined into a single structure achieved the highest C-index of 0.65 and 0.80 for RC and DMFS prediction, respectively. Models trained using these target structures as separate entities achieved the highest C-index of 0.70 for OS.CONCLUSION: Incorporating lymph node spatial information improved the prediction performance for RC, DMFS, and OS.
AB - BACKGROUND AND PURPOSE: Deep learning (DL) models can extract prognostic image features from pre-treatment PET/CT scans. The study objective was to explore the potential benefits of incorporating pathologic lymph node (PL) spatial information in addition to that of the primary tumor (PT) in DL-based models for predicting local control (LC), regional control (RC), distant-metastasis-free survival (DMFS), and overall survival (OS) in oropharyngeal cancer (OPC) patients.MATERIALS AND METHODS: The study included 409 OPC patients treated with definitive (chemo)radiotherapy between 2010 and 2022. Patient data, including PET/CT scans, manually contoured PT (GTVp) and PL (GTVln) structures, clinical variables, and endpoints, were collected. Firstly, a DL-based method was employed to segment tumours in PET/CT, resulting in predicted probability maps for PT (TPMp) and PL (TPMln). Secondly, different combinations of CT, PET, manual contours and probability maps from 300 patients were used to train DL-based outcome prediction models for each endpoint through 5-fold cross validation. Model performance, assessed by concordance index (C-index), was evaluated using a test set of 100 patients.RESULTS: Including PL improved the C-index results for all endpoints except LC. For LC, comparable C-indices (around 0.66) were observed between models trained using only PT and those incorporating PL as additional structure. Models trained using PT and PL combined into a single structure achieved the highest C-index of 0.65 and 0.80 for RC and DMFS prediction, respectively. Models trained using these target structures as separate entities achieved the highest C-index of 0.70 for OS.CONCLUSION: Incorporating lymph node spatial information improved the prediction performance for RC, DMFS, and OS.
U2 - 10.1016/j.phro.2025.100733
DO - 10.1016/j.phro.2025.100733
M3 - Article
C2 - 40046573
SN - 2405-6316
VL - 33
JO - Physics and Imaging in Radiation Oncology
JF - Physics and Imaging in Radiation Oncology
M1 - 100733
ER -